Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

Ann Oncol. 2019 Jun 1;30(6):1017. doi: 10.1093/annonc/mdy529.
No abstract available

Publication types

  • Published Erratum